C. Rougeot

Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo‐cortical transmission

Yves Gioanni, C. Rougeot, Paul B. S. Clarke et al. · European Journal of Neuroscience · 1999 · 193 citations

Life Sciences, Neuroscience, Pharmacology +17

Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Laurence Arbibe, Kamen Koumanov, Daniel Vial et al. · Journal of Clinical Investigation · 1998 · 186 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways.

Hervé Javelot, Mohammed Messaoudi, Sèverine Garnier et al. · PubMed · 2010 · 66 citations

Medicine, Neuroscience, Pharmacology +17

Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects.

C. Rougeot, Francisco Robert, L Menz et al. · PubMed · 2010 · 64 citations

Medicine, Pharmacology, Neuropharmacology +16

Inhibitory Effect of Platelet-Activating Factor (PAF) on Luteinizing Hormone-Releasing Hormone and Somatostatin Release From Rat Median Eminence<i>in Vitro</i>Correlated with the Characterization of Specific PAF Receptor Sites in Rat Hypothalamus

Marie‐Pierre Junier, C. TIBERGHIEN, C. Rougeot et al. · Endocrinology · 1988 · 46 citations

Life Sciences, Pharmacology, Physiology +17